Cerebellar antibodies in post-stroke sera of acute ischemic stroke patients Kisagyi antitestek akut ischaemiás stroke-on átesett betegek szérumában


Creative Commons License

ATMACA M. M., Erdağ E., DEMİR S., YÜCEER KORKMAZ H., Atmaca M. Ç., KÜÇÜKALİ C. İ., ...Daha Fazla

Ideggyogyaszati Szemle, cilt.76, sa.11-12, ss.394-398, 2023 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76 Sayı: 11-12
  • Basım Tarihi: 2023
  • Doi Numarası: 10.18071/isz.76.0394
  • Dergi Adı: Ideggyogyaszati Szemle
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.394-398
  • Anahtar Kelimeler: stroke, ischemic stroke, antibody, cerebellar, autoimmunity
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background and purpose – Although serum anti-neuronal antibodies are found in acute ischemic stroke (AIS) patients, it is not completely clear whether they are already present before the cerebrovascular event or emerge thereafter. Methods – Sera of 21 consecutive first-ever AIS patients were collected within the first day of AIS (baseline), as well as 1 and 6 months after AIS. Well-characterized and novel anti-neuronal antibodies were investigated by cell-based assays, immunoblotting and indirect immunohistochemistry. Results – None of the AIS sera collected at different time points showed well-characterized antibodies. In 7 patients, 1- and 6-month sera (but not baseline sera) showed IgG mostly reacting with soma and dendrites of cerebellar Purkinje cells. Antibody-positive patients did not differ in terms of clinical and etiological features. Conclusion – Our results provide evidence for the antibody-triggering action of AIS. Although anti-cerebellar antibodies are not associated with the severity of stroke, they may potentially contribute to chronic post-stroke complications and disability.